(1 - 13 von 14
)
Heise.de: Aktuell | Technology Review | Heise Magazine
Marcus Hompesch, Chef des Profil Institute for Clinical Research in San Diego und Fachmann auf dem Gebiet, hält das Vorhaben für verantwortungslos und tollkühn: „Insulin herzustellen ist eine ...
Biohackers Aim To Make Homebrew Insulin, But Don't Try It Yet | WAMU
wamu.org
Insulin can be expensive even with insurance, and millions of people need it to stay alive. Proponents of the biohacking movement say it should be possible to...
War waged on diabetes, obesity - The San Diego Union-Tribunewww.sandiegouniontribune.com › business › biotech
www.sandiegouniontribune.com
· Marcus Hompesch has led the institute since it was established in as an offshoot of a metabolic research center in Germany. Hompesch ...
Landrat Dieter Patt besuchte Profil GmbH in Neuss: Gewinn für...
rp-online.de
Die Diabetes-Vorsorge steht bei der Neusser Profil GmbH, einem wissenschaftlichen Forschungsinstitut, im Mittelpunkt. Das Unternehmen bearbeitet im Auftrag
Zusammenarbeit bei Diabetes-Prävention: …
rp-online.de
Mit einer Reihenuntersuchung, bei der zunächst Freiwillige ihr persönliches Diabestes-Risiko ermitteln lassen können, wollen Dr. Marcus Hompesch und Prüfärztin Dr. Sabine Flesch zu ...
ProSciento Expands To Australia - Contract Pharma
www.contractpharma.com
The Australian government offers R&D tax incentives that make it a cost-effective location to carry out clinical trials
HighTide, Profil Institute team-up against diabetes and NAFLD - Healiowww.healio.com › news › hepatology › hightide-pr...
www.healio.com
· Marcus Hompesch. In the agreement, Profil will perform clinical research and development on HighTide's portfolio of drug candidates designed ...
ProSciento, Nordic Bioscience Partner to Develop Translational ...www.clinicalomics.com › ... › Biomarkers
www.insideprecisionmedicine.com
· ProSciento CEO Marcus Hompesch, M.D., said in a statement. “Bringing together our areas of expertise specific to NASH research provides a ...
Profil Institute Closes Nearly 200 Clinical Trials on Diabetes and...
diabetesnewsjournal.com
· Marcus Hompesch. “We've contributed important research to many current therapies providing exciting new treatment options for patients, but we ...
Profil Institute to use Mercodia ELISA to enhance diabetes, obesity...
www.nsmedicaldevices.com
Profil Institute for Clinical Research CEO Dr Marcus Hompesch said the centre will use the ELISA assays in its investigative standards for early ...
Profil Institute, Shenzhen HighTide partner to develop new therapies...
www.pharmabiz.com
Profil Institute, Shenzhen HighTide partner to develop new therapies for diabetes & NAFLD/NASH
Profil Institute and LMC Diabetes Launch Strategic Partnership to...
www.lmc.ca
... clinical trials, and we are delighted to welcome them as a strategic partner,” said Dr. Marcus Hompesch, Profil Institute Chairman and CEO.
mySugr forms partnership with Profil Institute in clinical validation...
medcitynews.com
Both groups will jointly design and execute a development program to enhance and validate the clinical and health economic impact of mySugr’s diabetes...
sortiert nach Relevanz / Datum